SCHEMBL9975979

SCHEMBL9975979

O=S(=O)(c1ccccc1)N1CCN(Cc2ncccc2O)CC1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.58
HIF1A Q16665 1/20 0.58
KDM4E B2RXH2 6/20 0.54
ALDH1A1 P00352 5/20 0.54
POLB P06746 2/20 0.54
PKM P14618 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
GAA P10253 2/20 0.54
MAPT P10636 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
MITF O75030 1/20 0.54
HTT P42858 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
ATM Q13315 1/20 0.50
TP53 P04637 1/20 0.50
RECQL P46063 1/20 0.49
TSHR P16473 1/20 0.48
KMT2A Q03164 1/20 0.47
HSD11B1 P28845 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24569015 0.82 CYP2C19 (0.83) CYP2C19HIF1AKDM4EALDH1A1GAA
SCHEMBL24569006 0.82 CYP2C19 (0.83) CYP2C19HIF1AKDM4EALDH1A1GAA
SCHEMBL9975978 0.80 KDM4E (0.65) CYP2C19KDM4EALDH1A1POLBPKM
SCHEMBL10037168 0.79 CYP2C19 (0.51) CYP2C19HIF1AKDM4EALDH1A1POLB
SCHEMBL9532332 0.77 CYP2C19 (0.66) CYP2C19HIF1AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9975981 0.76 BCHE (0.60) CYP2C19HIF1AKDM4EALDH1A1POLB
SCHEMBL9734270 0.76 CYP2C19 (0.97) CYP2C19HIF1AKDM4EALDH1A1POLB
SCHEMBL20476290 0.74 CYP2C19 (1.00) CYP2C19HIF1AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7131206 0.74 KDM4E (0.78) KDM4EALDH1A1POLBSMN1; SMN2GAA
SCHEMBL10037172 0.73 KDM4E (0.57) CYP2C19HIF1AKDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546397-B2 DNA methylation inhibitors THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-10-01 US disclosed
US-8546397-B2 DNA methylation inhibitors THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-10-01 US disclosed
US-20120157465-A1 DNA METHYLATION INHIBITORS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2012-06-21 US disclosed
US-20120157465-A1 DNA METHYLATION INHIBITORS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157465-A1 DNA METHYLATION INHIBITORS MECP2, DNMT1, DNMT3B CYP2C19 2856/4885HIF1A 2746/4885KDM4E 427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.